Concepedia

Publication | Open Access

Preliminary Report of the Effects of Complement Suppression With Pexelizumab on Neurocognitive Decline After Coronary Artery Bypass Graft Surgery

DOIFull Paper Access

62

Citations

25

References

2004

Year

Joseph P. Mathew, Stanton K. Shernan, William D. White, Jane C.K. Fitch, John C. Chen, Leonard Bell, Mark F. Newman
Stroke

Abstract

Pexelizumab administration for 24 hours perioperatively had no effect on global measures of cognition but may reduce dysfunction in the visuo-spatial domain.

References

YearCitations

Page 1